Dr Katie Gallacher

  • Senior Clinical Research Fellow (General Practice & Primary Care)

telephone: 0141 330 8323
email: Katie.Gallacher@glasgow.ac.uk

School of Health & Wellbeing, Clarice Pears Building, 90 Byres Road, Glasgow, G12 8TB

Import to contacts

ORCID iDhttps://orcid.org/0000-0001-8620-8758

Biography

Dr Katie Gallacher joined General Practice and Primary Care in 2009 as an Academic Fellow. She graduated from the University of Glasgow in 2004, after completing an intercalated BSc (MedSci) in developmental medicine in 2002. She completed her GP training in the south of Glasgow in 2008 and now works as a GP.

Dr Gallacher completed her PhD entitled An exploration of treatment burden and patient capacity in people with stroke in 2016. She was awarded a Stroke Association Clinical Lectureship in 2017 and now works as a senior clinical lecturer in General Practice and Primary Care. She has a special interest in research that explores and measures the workload of self-management for people with long-term conditions including stroke, and in the development and testing of interventions that minimize this workload and maximize capacity to manage health problems.

She represents the Royal College of General Practitioners on the National Advisory Committee for Stroke, and in the UK Stroke Forum. 

Follow Katie Gallacher on Twitter

https://twitter.com/GallacherKatie

Research interests

 

  • Management of long term conditions
  • Stroke patient care
  • Multimorbidity
  • Treatment burden
  • Patient capacity
  • Minimally disruptive medicine
  • Developing patient reported outcome measures
  • The patient experience
  • Mixed methods research

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010
Number of items: 42.

2024

Erhahiemen, P. , O'Donnell, C. A., Gallacher, K. and Nicholl, B. I. (2024) A systematic review of the experience of treatment burden of digital health for military personnel in primary healthcare. Health Open Research, 6(9), (doi: 10.12688/healthopenres.13599.1)

McMahon, D., Dixon, D., Quinn, T. and Gallacher, K. I. (2024) The Acceptability of post-stroke cognitive testing through the lens of the theory of acceptability, a qualitative study. Cerebral Circulation - Cognition and Behavior, 6, 100197. (doi: 10.1016/j.cccb.2023.100197) (PMID:38226361) (PMCID:PMC10788191)

2023

Burton, J. K. , Drummond, M., Gallacher, K. I. and Quinn, T. J. (2023) Listening and learning: a qualitative study of Scottish care home staff experiences of managing COVID-19 between March 2020-August 2022. BMC Geriatrics, 23(1), 544. (doi: 10.1186/s12877-023-04251-z) (PMID:37679720) (PMCID:PMC10485989)

Wood, K., Sardar, A., Eton, D. T., Mair, F. S. , Kidd, L. , Quinn, T. J. and Gallacher, K. I. (2023) Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure. Disability and Rehabilitation, (doi: 10.1080/09638288.2023.2241360) (PMID:37545161) (Early Online Publication)

Hanlon, P. , Burton, J. K. , Quinn, T. J. , Mair, F. S. , McAllister, D. , Lewsey, J. and Gallacher, K. I. (2023) Prevalence, measurement and implications of frailty in stroke survivors: an analysis of three global aging cohorts. International Journal of Stroke, 18(6), pp. 720-727. (doi: 10.1177/17474930231151847) (PMID:36621981) (PMCID:PMC10311928)

May, C. R., Chew-Graham, C. A., Gallacher, K. I. , Gravenhorst, K. C., Mair, F. S., Nolte, E. and Richardson, A. (2023) EXPERTS II - How are patient and caregiver participation in health and social care shaped by experienced burden of treatment and social inequalities? Protocol for a qualitative synthesis. NIHR Open Research, 3, 31. (doi: 10.3310/nihropenres.13411.1) (PMID:37881470) (PMCID:PMC10593344)

Gallacher, K. I. , Taylor-Rowan, M. , Eton, D. T., McLeod, H. , Kidd, L. , Wood, K., Sardar, A., Quinn, T. J. and Mair, F. S. (2023) Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke. Health Open Research, 5, 17. (doi: 10.12688/healthopenres.13334.1)

Adam, R., Nair, R., Duncan, L. F., Yeoh, E., Chan, J., Vilenskaya, V. and Gallacher, K. I. (2023) Treatment burden in individuals living with and beyond cancer: a systematic review of qualitative literature. PLoS ONE, 18(5), e0286308. (doi: 10.1371/journal.pone.0286308) (PMID:37228101) (PMCID:PMC10212163)

2022

Boehmer, K. R., Gallacher, K. I. , Lippiett, K. A., Mair, F. S. , May, C. R. and Montori, V. M. (2022) Minimally disruptive medicine – progress 10 years later. Mayo Clinic Proceedings, 97(2), pp. 210-220. (doi: 10.1016/j.mayocp.2021.09.003) (PMID:35120690)

Kidd, L. et al. (2022) Supported self-management in community stroke rehabilitation: what is it and how does it work? A protocol for a realist evaluation study. BMJ Open, 12(1), e055491. (doi: 10.1136/bmjopen-2021-055491) (PMID:35058265) (PMCID:PMC8783824)

2021

Stewart, C., Gallacher, K. , Nakham, A., Cruickshank, M., Newlands, R., Bond, C., Myint, P. K., Bhattacharya, D. and Mair, F. S. (2021) Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review. International Journal of Clinical Pharmacy, 43(6), pp. 1451-1460. (doi: 10.1007/s11096-021-01293-4) (PMID:34173123)

Cunningham, Y. et al. (2021) Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden: a qualitative study. Frontiers in Pharmacology, 12, 608208. (doi: 10.3389/fphar.2021.608208) (PMID:34867311) (PMCID:PMC8633300)

Mason, B. et al. (2021) Core outcome measures for palliative and end-of-life research after severe stroke: mixed-method Delphi study. Stroke, 52(11), pp. 3507-3513. (doi: 10.1161/strokeaha.120.032650) (PMID:34266306) (PMCID:PMC8547585)

Hanlon, P. et al. (2021) Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support. Wellcome Open Research, 6, 257. (doi: 10.12688/wellcomeopenres.17238.1) (PMID:35928807) (PMCID:PMC9308000)

Jani, B. D. , McQueenie, R., Nicholl, B. I. , Field, R. , Hanlon, P. , Gallacher, K. I. , Mair, F. S. and Lewsey, J. (2021) Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study. BMC Medicine, 19, 8. (doi: 10.1186/s12916-020-01878-2) (PMID:33430840) (PMCID:PMC7802201)

2020

Hanlon, P. et al. (2020) Assessing risks of polypharmacy involving medications with anticholinergic properties. Annals of Family Medicine, 18(2), pp. 148-155. (doi: 10.1370/afm.2501) (PMID:32152019) (PMCID:PMC7062487)

Kyle, J., Skleparis, D. , Mair, F. S. and Gallacher, K. I. (2020) What helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives. BMJ Open, 10(3), e034113. (doi: 10.1136/bmjopen-2019-034113) (PMID:32193265)

2019

Gallacher, K. , Quinn, T. , Kidd, L. , Eton, D., Elliot, J., Johnston, N., Erwin, P. J. and Mair, F. (2019) Systematic review of patient-reported measures of treatment burden in stroke. BMJ Open, 9(9), e029258. (doi: 10.1136/bmjopen-2019-029258) (PMID:31533946) (PMCID:PMC6756342)

Stewart, C., Gallacher, K. , Nakham, A., Cruickshank, M., Newlands, R., Bond, C., Myint, P. K., Bhattacharya, D. and Mair, F. S. (2019) Barriers and facilitators to reducing anticholinergic burden from the perspectives of patients, their carers, and healthcare professionals: a protocol for qualitative evidence synthesis. Journal of Evidence-Based Medicine, 12(3), pp. 227-231. (PMID:31441236)

Gallacher, K. I. , Jani, B. D. , Hanlon, P. , Nicholl, B. I. and Mair, F. S. (2019) Multimorbidity in stroke. Stroke, 50(7), pp. 1919-1926. (doi: 10.1161/STROKEAHA.118.020376) (PMID:31233391)

Jani, B. D. , Hanlon, P. , Nicholl, B. I. , McQueenie, R., Gallacher, K. I. , Lee, D. and Mair, F. S. (2019) Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank Cohort. BMC Medicine, 17, 74. (doi: 10.1186/s12916-019-1305-x) (PMID:30967141) (PMCID:PMC6456941)

Quinn, T. J. , Mooijaart, S. P., Gallacher, K. and Burton, J. K. (2019) Acute care assessment of older adults living with frailty. British Medical Journal, 364, l13. (doi: 10.1136/bmj.l13)

2018

Jani, B. D. , Nicholl, B. I. , McQueenie, R., Connelly, D. T., Hanlon, P. , Gallacher, K. I. , Lee, D. and Mair, F. S. (2018) Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace, 20, f329-f336. (doi: 10.1093/europace/eux322) (PMID:29112751) (PMCID:PMC6277149)

Gallacher, K. I. , McQueenie, R., Nicholl, B. , Jani, B. D. , Lee, D. and Mair, F. S. (2018) Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants. Journal of Comorbidity, 8(1), pp. 1-8. (doi: 10.15256/joc.2018.8.129)

Gallacher, K. and Quinn, T. J. (2018) The LAST word on coaching as a stroke intervention? Stroke, 49(2), pp. 279-280. (doi: 10.1161/STROKEAHA.117.020001) (PMID:29284726)

Gallacher, K. L. , May, C. R., Langhorne, P. and Mair, F. S. (2018) A conceptual model of treatment burden and patient capacity in stroke. BMC Family Practice, 19(1), 9. (doi: 10.1186/s12875-017-0691-4) (PMID:29316892) (PMCID:PMC5759246)

Hanlon, P. , Nicholl, B. I. , Jani, B. D. , McQueenie, R., Lee, D. , Gallacher, K. I. and Mair, F. S. (2018) Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open, 8(1), e018404. (doi: 10.1136/bmjopen-2017-018404) (PMID:29332840) (PMCID:PMC5781016)

2017

Mair, F. S. and Gallacher, K. I. (2017) Multimorbidity: what next? British Journal of General Practice, 67(659), pp. 248-249. (doi: 10.3399/bjgp17X690965)

2016

Mair, F. and Gallacher, K. (2016) Treatment Burden. Discussion Paper. SSPC, Glasgow.

2015

Abu Dabrh, A.M., Gallacher, K. , Boehmer, K.R., Hargraves, I.G. and Mair, F.S. (2015) Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare. Journal of the Royal College of Physicians of Edinburgh, 45(2), pp. 114-117. (doi: 10.4997/JRCPE.2015.205)

Gallacher, K. (2015) Final Report of Clinical Academic Training Fellowship, CAF 10/03. Project Report. Chief Scientist Office.

2014

Gallacher, K. I. , Montori, V. M., May, C. R. and Mair, F. S. (2014) Treatment burden and multimorbidity. In: Mercer, S. W., Salisbury, C. and Fortin, M. (eds.) ABC of Multimorbidity. Series: ABC Series. Wiley-Blackwell: Oxford, pp. 30-33. ISBN 9781118383889

Gallacher, K. I. , Batty, G. D., McLean, G., Mercer, S. W. , Guthrie, B., May, C. R., Langhorne, P. and Mair, F. S. (2014) Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden. BMC Medicine, 12(151), (doi: 10.1186/s12916-014-0151-0)

Leppin, A. L. et al. (2014) Preventing 30-day hospital readmissions. JAMA Internal Medicine, 174(7), pp. 1095-1107. (doi: 10.1001/jamainternmed.2014.1608)

May, C. R. et al. (2014) Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research, 14(281), (doi: 10.1186/1472-6963-14-281)

2013

Cameron, E.J. et al. (2013) Randomised controlled trial of azithromycin in smokers with asthma. European Respiratory Journal, 42(5), pp. 1412-1415. (doi: 10.1183/09031936.00093913)

Gallacher, K. et al. (2013) Qualitative systematic reviews of treatment burden in stroke, heart failure and diabetes: methodological challenges and solutions. BMC Medical Research Methodology, 13(10), (doi: 10.1186/1471-2288-13-10)

Gallacher, K. et al. (2013) Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Medicine, 10(6), e1001473. (doi: 10.1371/journal.pmed.1001473)

2011

Gallacher, K. , May, C.R., Montori, V.M. and Mair, F.S. (2011) Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Annals of Family Medicine, 9(3), pp. 235-243. (doi: 10.1370/afm.1249)

Mair, F.S. , Browne, S. , Morrison, D. , Gallacher, K. , Macleod, U. and May, C.R. (2011) Treatment burden in end stage heart failure (ESHF): a qualitative study. BMJ Supportive and Palliative Care, 1(s1), A8. (doi: 10.1136/bmjspcare-2011-000020.21)

2010

Gallacher, K.I. , May, C.R., Montori, V.M. and Mair, F.S. (2010) Assessing treatment burden in chronic heart failure patients. Heart, 96(s1), A37-A38. (doi: 10.1136/hrt.2010.195966.11)

Gallacher, K. and Mair, F. (2010) Final Report, Chief Scientist Office CAF CZG/3/22. Project Report. Chief Scientist Office.

This list was generated on Thu Apr 18 14:05:15 2024 BST.
Jump to: Articles | Book Sections | Research Reports or Papers
Number of items: 42.

Articles

Erhahiemen, P. , O'Donnell, C. A., Gallacher, K. and Nicholl, B. I. (2024) A systematic review of the experience of treatment burden of digital health for military personnel in primary healthcare. Health Open Research, 6(9), (doi: 10.12688/healthopenres.13599.1)

McMahon, D., Dixon, D., Quinn, T. and Gallacher, K. I. (2024) The Acceptability of post-stroke cognitive testing through the lens of the theory of acceptability, a qualitative study. Cerebral Circulation - Cognition and Behavior, 6, 100197. (doi: 10.1016/j.cccb.2023.100197) (PMID:38226361) (PMCID:PMC10788191)

Burton, J. K. , Drummond, M., Gallacher, K. I. and Quinn, T. J. (2023) Listening and learning: a qualitative study of Scottish care home staff experiences of managing COVID-19 between March 2020-August 2022. BMC Geriatrics, 23(1), 544. (doi: 10.1186/s12877-023-04251-z) (PMID:37679720) (PMCID:PMC10485989)

Wood, K., Sardar, A., Eton, D. T., Mair, F. S. , Kidd, L. , Quinn, T. J. and Gallacher, K. I. (2023) Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure. Disability and Rehabilitation, (doi: 10.1080/09638288.2023.2241360) (PMID:37545161) (Early Online Publication)

Hanlon, P. , Burton, J. K. , Quinn, T. J. , Mair, F. S. , McAllister, D. , Lewsey, J. and Gallacher, K. I. (2023) Prevalence, measurement and implications of frailty in stroke survivors: an analysis of three global aging cohorts. International Journal of Stroke, 18(6), pp. 720-727. (doi: 10.1177/17474930231151847) (PMID:36621981) (PMCID:PMC10311928)

May, C. R., Chew-Graham, C. A., Gallacher, K. I. , Gravenhorst, K. C., Mair, F. S., Nolte, E. and Richardson, A. (2023) EXPERTS II - How are patient and caregiver participation in health and social care shaped by experienced burden of treatment and social inequalities? Protocol for a qualitative synthesis. NIHR Open Research, 3, 31. (doi: 10.3310/nihropenres.13411.1) (PMID:37881470) (PMCID:PMC10593344)

Gallacher, K. I. , Taylor-Rowan, M. , Eton, D. T., McLeod, H. , Kidd, L. , Wood, K., Sardar, A., Quinn, T. J. and Mair, F. S. (2023) Protocol for the development and validation of a patient reported measure (PRM) of treatment burden in stroke. Health Open Research, 5, 17. (doi: 10.12688/healthopenres.13334.1)

Adam, R., Nair, R., Duncan, L. F., Yeoh, E., Chan, J., Vilenskaya, V. and Gallacher, K. I. (2023) Treatment burden in individuals living with and beyond cancer: a systematic review of qualitative literature. PLoS ONE, 18(5), e0286308. (doi: 10.1371/journal.pone.0286308) (PMID:37228101) (PMCID:PMC10212163)

Boehmer, K. R., Gallacher, K. I. , Lippiett, K. A., Mair, F. S. , May, C. R. and Montori, V. M. (2022) Minimally disruptive medicine – progress 10 years later. Mayo Clinic Proceedings, 97(2), pp. 210-220. (doi: 10.1016/j.mayocp.2021.09.003) (PMID:35120690)

Kidd, L. et al. (2022) Supported self-management in community stroke rehabilitation: what is it and how does it work? A protocol for a realist evaluation study. BMJ Open, 12(1), e055491. (doi: 10.1136/bmjopen-2021-055491) (PMID:35058265) (PMCID:PMC8783824)

Stewart, C., Gallacher, K. , Nakham, A., Cruickshank, M., Newlands, R., Bond, C., Myint, P. K., Bhattacharya, D. and Mair, F. S. (2021) Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review. International Journal of Clinical Pharmacy, 43(6), pp. 1451-1460. (doi: 10.1007/s11096-021-01293-4) (PMID:34173123)

Cunningham, Y. et al. (2021) Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden: a qualitative study. Frontiers in Pharmacology, 12, 608208. (doi: 10.3389/fphar.2021.608208) (PMID:34867311) (PMCID:PMC8633300)

Mason, B. et al. (2021) Core outcome measures for palliative and end-of-life research after severe stroke: mixed-method Delphi study. Stroke, 52(11), pp. 3507-3513. (doi: 10.1161/strokeaha.120.032650) (PMID:34266306) (PMCID:PMC8547585)

Hanlon, P. et al. (2021) Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support. Wellcome Open Research, 6, 257. (doi: 10.12688/wellcomeopenres.17238.1) (PMID:35928807) (PMCID:PMC9308000)

Jani, B. D. , McQueenie, R., Nicholl, B. I. , Field, R. , Hanlon, P. , Gallacher, K. I. , Mair, F. S. and Lewsey, J. (2021) Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study. BMC Medicine, 19, 8. (doi: 10.1186/s12916-020-01878-2) (PMID:33430840) (PMCID:PMC7802201)

Hanlon, P. et al. (2020) Assessing risks of polypharmacy involving medications with anticholinergic properties. Annals of Family Medicine, 18(2), pp. 148-155. (doi: 10.1370/afm.2501) (PMID:32152019) (PMCID:PMC7062487)

Kyle, J., Skleparis, D. , Mair, F. S. and Gallacher, K. I. (2020) What helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives. BMJ Open, 10(3), e034113. (doi: 10.1136/bmjopen-2019-034113) (PMID:32193265)

Gallacher, K. , Quinn, T. , Kidd, L. , Eton, D., Elliot, J., Johnston, N., Erwin, P. J. and Mair, F. (2019) Systematic review of patient-reported measures of treatment burden in stroke. BMJ Open, 9(9), e029258. (doi: 10.1136/bmjopen-2019-029258) (PMID:31533946) (PMCID:PMC6756342)

Stewart, C., Gallacher, K. , Nakham, A., Cruickshank, M., Newlands, R., Bond, C., Myint, P. K., Bhattacharya, D. and Mair, F. S. (2019) Barriers and facilitators to reducing anticholinergic burden from the perspectives of patients, their carers, and healthcare professionals: a protocol for qualitative evidence synthesis. Journal of Evidence-Based Medicine, 12(3), pp. 227-231. (PMID:31441236)

Gallacher, K. I. , Jani, B. D. , Hanlon, P. , Nicholl, B. I. and Mair, F. S. (2019) Multimorbidity in stroke. Stroke, 50(7), pp. 1919-1926. (doi: 10.1161/STROKEAHA.118.020376) (PMID:31233391)

Jani, B. D. , Hanlon, P. , Nicholl, B. I. , McQueenie, R., Gallacher, K. I. , Lee, D. and Mair, F. S. (2019) Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank Cohort. BMC Medicine, 17, 74. (doi: 10.1186/s12916-019-1305-x) (PMID:30967141) (PMCID:PMC6456941)

Quinn, T. J. , Mooijaart, S. P., Gallacher, K. and Burton, J. K. (2019) Acute care assessment of older adults living with frailty. British Medical Journal, 364, l13. (doi: 10.1136/bmj.l13)

Jani, B. D. , Nicholl, B. I. , McQueenie, R., Connelly, D. T., Hanlon, P. , Gallacher, K. I. , Lee, D. and Mair, F. S. (2018) Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace, 20, f329-f336. (doi: 10.1093/europace/eux322) (PMID:29112751) (PMCID:PMC6277149)

Gallacher, K. I. , McQueenie, R., Nicholl, B. , Jani, B. D. , Lee, D. and Mair, F. S. (2018) Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants. Journal of Comorbidity, 8(1), pp. 1-8. (doi: 10.15256/joc.2018.8.129)

Gallacher, K. and Quinn, T. J. (2018) The LAST word on coaching as a stroke intervention? Stroke, 49(2), pp. 279-280. (doi: 10.1161/STROKEAHA.117.020001) (PMID:29284726)

Gallacher, K. L. , May, C. R., Langhorne, P. and Mair, F. S. (2018) A conceptual model of treatment burden and patient capacity in stroke. BMC Family Practice, 19(1), 9. (doi: 10.1186/s12875-017-0691-4) (PMID:29316892) (PMCID:PMC5759246)

Hanlon, P. , Nicholl, B. I. , Jani, B. D. , McQueenie, R., Lee, D. , Gallacher, K. I. and Mair, F. S. (2018) Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open, 8(1), e018404. (doi: 10.1136/bmjopen-2017-018404) (PMID:29332840) (PMCID:PMC5781016)

Mair, F. S. and Gallacher, K. I. (2017) Multimorbidity: what next? British Journal of General Practice, 67(659), pp. 248-249. (doi: 10.3399/bjgp17X690965)

Abu Dabrh, A.M., Gallacher, K. , Boehmer, K.R., Hargraves, I.G. and Mair, F.S. (2015) Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare. Journal of the Royal College of Physicians of Edinburgh, 45(2), pp. 114-117. (doi: 10.4997/JRCPE.2015.205)

Gallacher, K. I. , Batty, G. D., McLean, G., Mercer, S. W. , Guthrie, B., May, C. R., Langhorne, P. and Mair, F. S. (2014) Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden. BMC Medicine, 12(151), (doi: 10.1186/s12916-014-0151-0)

Leppin, A. L. et al. (2014) Preventing 30-day hospital readmissions. JAMA Internal Medicine, 174(7), pp. 1095-1107. (doi: 10.1001/jamainternmed.2014.1608)

May, C. R. et al. (2014) Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research, 14(281), (doi: 10.1186/1472-6963-14-281)

Cameron, E.J. et al. (2013) Randomised controlled trial of azithromycin in smokers with asthma. European Respiratory Journal, 42(5), pp. 1412-1415. (doi: 10.1183/09031936.00093913)

Gallacher, K. et al. (2013) Qualitative systematic reviews of treatment burden in stroke, heart failure and diabetes: methodological challenges and solutions. BMC Medical Research Methodology, 13(10), (doi: 10.1186/1471-2288-13-10)

Gallacher, K. et al. (2013) Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Medicine, 10(6), e1001473. (doi: 10.1371/journal.pmed.1001473)

Gallacher, K. , May, C.R., Montori, V.M. and Mair, F.S. (2011) Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Annals of Family Medicine, 9(3), pp. 235-243. (doi: 10.1370/afm.1249)

Mair, F.S. , Browne, S. , Morrison, D. , Gallacher, K. , Macleod, U. and May, C.R. (2011) Treatment burden in end stage heart failure (ESHF): a qualitative study. BMJ Supportive and Palliative Care, 1(s1), A8. (doi: 10.1136/bmjspcare-2011-000020.21)

Gallacher, K.I. , May, C.R., Montori, V.M. and Mair, F.S. (2010) Assessing treatment burden in chronic heart failure patients. Heart, 96(s1), A37-A38. (doi: 10.1136/hrt.2010.195966.11)

Book Sections

Gallacher, K. I. , Montori, V. M., May, C. R. and Mair, F. S. (2014) Treatment burden and multimorbidity. In: Mercer, S. W., Salisbury, C. and Fortin, M. (eds.) ABC of Multimorbidity. Series: ABC Series. Wiley-Blackwell: Oxford, pp. 30-33. ISBN 9781118383889

Research Reports or Papers

Mair, F. and Gallacher, K. (2016) Treatment Burden. Discussion Paper. SSPC, Glasgow.

Gallacher, K. (2015) Final Report of Clinical Academic Training Fellowship, CAF 10/03. Project Report. Chief Scientist Office.

Gallacher, K. and Mair, F. (2010) Final Report, Chief Scientist Office CAF CZG/3/22. Project Report. Chief Scientist Office.

This list was generated on Thu Apr 18 14:05:15 2024 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Exploring the relationship between burden of treatment and patient capacity on patient trajectories in patients with end-stage renal failure
    Office of the Chief Scientific Adviser
    2023 - 2025
     
  • Development of a patient reported measure of treatment burden in stroke.
    Office of the Chief Scientific Adviser
    2021 - 2023
     
  • How are patient and caregiver participation in health and social care shaped by experienced burden of treatment and social inequalities? A qualitative synthesis
    National Institute for Health Research
    2021 - 2022
     
  • Development and content validation of a patient reported measure (PRM) of treatment burden in stroke
    NHS Greater Glasgow and Clyde Endowment Funds
    2020 - 2021
     
  • Quantum-Inspired Imaging for Remote Monitoring of Health & Disease in Community Healthcare
    Engineering and Physical Sciences Research Council
    2020 - 2025
     
  • Understanding stakeholder views regarding the design of a trial intervention to reduce anticholinergic burden
    Chief Scientist Office
    2019 - 2019
     
  • Reaching consensus for core outcome measures for palliative and end-of-life care after severe stroke
    Chief Scientist Office
    2019 - 2019
     
  • Implementation of supported stroke self-management: what does it look like and what makes it `work in different contexts
    Stroke Association
    2018 - 2020
     
  • An evidence synthesis suite to inform a future randomised trial of reducing anticholinergic related harm in older adults
    Dunhill Medical Trust
    2018 - 2020
     
  • Optimising healthcare for stroke survivors - a study of health professional perspectives on minimising treatment burden and maximising patient capacity
    NHS Greater Glasgow and Clyde Endowment Funds
    2018 - 2018
     
  • Stroke Association Clinical Lectureship
    Stroke Association
    2017 - 2022
     
  • Patterns of co-morbidity in stroke and associations with hospital admission and mortality - an observational study
    The Carnegie Trust for the Universities of Scotland
    2016 - 2016
     
  • Understanding treatment burden in Stroke Patients
    Chief Scientist Office
    2010 - 2015
     

Supervision

  • Erhahiemen, Paul
    Optimisation of patient outcomes by identifying the priorities and barriers to the adaptation and implementation of digital health and Artificial Intelligence (AI) in the management of chronic diseases in primary care

Research datasets

Jump to: 2022
Number of items: 1.

2022

ROSS, K. , Keith, N. , Abbott, L., Adams, C., Aitken, E., Aslett, O., Basra, S., Bell, I., Bradley, J., Brown, T., Brown, W., Chen, R., Cheskin, L., Corrie, R., de Vries, E., Defty, E., Drake, H., Dunlop, H., Emadi, A. , Evans, J. , Everett, S., Feng, Z., Fraser, A., Gallacher, K. , Gaynor-Kirk, E., Halsey, C. , Harris, F., Hu, J., Hush, G., Jamieson, N. , Jameison, V., Jones, R. , Just, L., Lembo, T. , Lloyd, B., Ma, C.-L., Macdonald, S. , Mathias, M. , McAra, M., McCaffrey, B., Mccluskey, L.-A., Mchattie, L.-S., Mcneill, E., Milliken, A., Mogford, D., Morris, G., Nicoll, M., O'Brien, T., Onwuka, T., Papanastasatou, M., Perry, M. , Prosser, Z., Proudfoot, B., Raman Komnedath, S., Robinson, J. , Sleight, R., Smith, P., Stricevic, M., Tharp, B., Thoresson, V., Thorne, J., Vansteenhouse, H., Welisch, G. and Wu, O. (2022) Symbiotic Futures: Health, Well-being and Care in the Post-Covid World. [Data Collection]

This list was generated on Thu Apr 18 14:05:17 2024 BST.